These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23008823)

  • 21. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
    J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Goto T; Tanimoto K; Ishibashi M; Okamura S
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1227-32. PubMed ID: 22902447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
    von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What does chemotherapy have to offer patients with advanced-stage non-small cell lung cancer?
    Kris MG
    Semin Oncol; 1998 Jun; 25(3 Suppl 8):1-4. PubMed ID: 9704668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer.
    Splinter TA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
    Jiang J; Liang X; Zhou X; Huang R; Chu Z
    Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent development in the treatment of lung cancer: from the point of view of the medical oncologist].
    Joss R
    Schweiz Med Wochenschr; 2000 May; 130(19):684-90. PubMed ID: 10846762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of chemotherapy dose intensity in lung cancer.
    Crawford J
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):25-31. PubMed ID: 15726536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can weight loss at presentation predict patient outcome in lung cancer?
    Temel J
    Nat Clin Pract Oncol; 2004 Dec; 1(2):68-9. PubMed ID: 16264819
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-effectiveness of adding granulocyte colony-stimulating factor to primary prophylaxis with antibiotics in small-cell lung cancer.
    Timmer-Bonte JN; Adang EM; Smit HJ; Biesma B; Wilschut FA; Bootsma GP; de Boo TM; Tjan-Heijnen VC
    J Clin Oncol; 2006 Jul; 24(19):2991-7. PubMed ID: 16682725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
    Di Maio M; Gallo C; Leighl NB; Piccirillo MC; Daniele G; Nuzzo F; Gridelli C; Gebbia V; Ciardiello F; De Placido S; Ceribelli A; Favaretto AG; de Matteis A; Feld R; Butts C; Bryce J; Signoriello S; Morabito A; Rocco G; Perrone F
    J Clin Oncol; 2015 Mar; 33(8):910-5. PubMed ID: 25624439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy.
    Sánchez-Lara K; Ugalde-Morales E; Motola-Kuba D; Green D
    Br J Nutr; 2013 Mar; 109(5):894-7. PubMed ID: 22691288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The quality of life of non-small cell lung cancer patients treated with chemotherapy.
    Karczmarek-Borowska B; Pelc M; Rabiej E; Grądalska-Lampart M
    Pneumonol Alergol Pol; 2014; 82(4):349-57. PubMed ID: 24964238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study.
    Lagrange A; Decoux D; Briot N; Hennequin A; Coudert B; Desmoulins I; Bertaut A
    Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():49-55. PubMed ID: 31430616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Erythropoietin is a novel therapeutic option in the treatment of anemia caused by small cell lung cancer].
    Tamási L; Bohács A; Wollák A; Magyar P
    Magy Onkol; 2006; 50(3):243-6. PubMed ID: 17099785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'", by P. A. Bunn Jr (Ann Oncol 2001; 12: 1339-1340).
    Tjan-Heijnen VC; Postmus PE; Ardizzoni A;
    Ann Oncol; 2002 Mar; 13(3):485-6; author reply 486-7. PubMed ID: 11996485
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent dermatophytosis (Majocchi granuloma) associated with chemotherapy-induced neutropenia.
    Lourdes LS; Mitchell CL; Glavin FL; Schain DC; Kaye FJ
    J Clin Oncol; 2014 Sep; 32(27):e92-4. PubMed ID: 24470005
    [No Abstract]   [Full Text] [Related]  

  • 40. [Support of hematological homeostasis during chemotherapy with taxanes].
    Koroleva IA; Mochalova AS
    Vopr Onkol; 2011; 57(6):784-8. PubMed ID: 22416398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.